Associations Between Cardiovascular Events and Nonergot Dopamine Agonists in Parkinson's Disease

BACKGROUND: Knowledge of possible cardiovascular risks from Parkinson's disease (PD) medications is critical to informing safe and effective treatment decisions. The objective of our study was to determine whether PD patients treated with nonergot dopamine agonists (DAs) are at increased risk o...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Mov Disord Clin Pract
Hlavní autoři: Crispo, James A.G., Willis, Allison W., Thibault, Dylan P., Fortin, Yannick, Emons, Matthew, Bjerre, Lise M., Kohen, Dafna E., Perez‐Lloret, Santiago, Mattison, Donald, Krewski, Daniel
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2015
Témata:
Research Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6178630/
https://ncbi.nlm.nih.gov/pubmed/30363519
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mdc3.12286
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky